Quercetin and the growth of leukemic progenitors

Leukemia and Lymphoma

Volumn 23, Issue 1-2, 1996, Pages 49-53

  Larocca, Luigi M ^a   Teofili, Luciana ^a   Maggiano, Nicola ^a   Piantelli, Mauro ^b   Ranelletti, Franco O ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Acute leukemias; Flavonoids; Heat shock proteins; Quercetin; Transforming growth factor 1; Type II estrogen binding sites

Indexed keywords

ANTILEUKEMIC AGENT; BIOFLAVONOID; CYTARABINE; ESTROGEN RECEPTOR; QUERCETIN; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER INHIBITION; CELL CYCLE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; ESTROGEN BINDING; HEAT TOLERANCE; HUMAN; HYPERTHERMIC THERAPY; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; REVIEW; STEM CELL;

EID: 0029823284     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054801     Document Type: Review

References (51)

1. Harborne, J. B. (1988) Flavonoids in the environment: structure-activity relationships. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medical Properties, edited by V Cody, E. Middleton Jr., J. B Harborne and A. Beretz, pp. 17-29. New York: Alan R. Liss, Inc.
2. Wollenweber, E. (1988) Occurence of flavonoid aglycones in medicinal plants. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medical Properties, edited by V. Cody, E. Middleton Jr., J B. Harborne and A. Beretz, pp. 17-29. New York: Alan R. Liss, Inc.
3. Kühnau, J. (1976) The flavonoids, a class of semi-essential food components: their role in human nutrition. Wld. Rev. Nutrition Diet, 24, 117-191.
4. Bjeldanese, L. F. and Chang, G W. (1977) Mutagenic activity of quercetin and related compounds. Science, 197, 577-578.
5. Macgregor, J. T. (1986) Genetic toxicology of dietary flavonoids. Prog. Clin. Biol. Res., 213, 33-43.
6. Ambrose, A. M., Robbins, D. J. and Deeds, F (1951) comparative toxicities of quercetin and quercitrin. J. Am. Pharm. Assoc., 41, 119-122.
7. Levy, J., Teverstein, I., Marbach, M , Radian, S. and Sharoni, Y (1984) Tyrosine protein Kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin. Bichem. Biophys. Res. Commun., 123, 1227-1233.
8. Cochet, C., Feige, J. J., Pirollet, F., Keramidas, M. and Chambaz, E. M. (1982) Selective inhibition of a cyclic nucleotide-independent protein kinase (G type casein kinase) by quercetin and related polyphenols. Biochem. Pharmacol., 31, 1357-1361
9. Gschwendt, M., Horn, F., Kittstein, W. and Marks, F. (1983) Inhibition of the calcium- and phospholipid-dependent protein kinase activity from brain mouse cytosol by quercetin. Biochem Biophys. Res. Commun., 117, 444-447.
10. Srivastava, A. K. (1985) Inhibition of phosphorylase kinase and tyrosine protein kinase activities by quercetin. Biochem. Biophys. Res. Commun., 131, 1-5.
11. Matter, W. F., Brown, R. F. and Vlahos, C. J. (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys. Res. Commun., 186, 624-631.
12. Belt, J. A., Thomas, J. A., Buchsbaum, R. N. and Racker, E. (1979) Inhibition of lactate transport and glycolisis in Ehrlich ascites tumor cells by bioflavonoids. Biochemestry, 18, 3506-3511.
13. Graziani, Y. and Chayoth, R. (1979) Regulation of cyclic AMP level and synthesis of DNA, RNA and protein by quercetin in Ehrlich ascites tumor cells. Biochem. Pharmacol., 28, 397-403.
14. +) adenosine triphosphatase and its partial reactions by quercetin. Biochemestry, 15, 4951-4956.
15. ++)-ATPase of sarcoplasmic reticulum. J. Biol. Chem., 256, 887-892.
16. Hosokawa, N., Hirayoshi, K., Nakai, A., Hosokawa, Y., Marui, N., Yoshida, M., Sakai, T., Nishino, H., Aoike, A., Kawai, K. and Nagata, K. (1990) Flavonoids inhibit the expression of heat shock proteins. Cell Struct. Funct., 15, 393-401.
17. Hosokawa, N., Hirayoshi, K., Kudo, H., Takechi, H., Aoike, A., Kawai, K. and Nagata, K. (1992) Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol. Cell. Biol., 12, 3490-3498.
18. Lee, Y. J., Erdos, G., Hou, Z-z., Kim, S. H., Kim, J. H., Cho, J. M. and Perry, P. M. (1994) Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells. Mol. Cell. Biochem., 137, 141-154.
19. Suolinna, E. M., Buchsbaum, R. N. and Racker, E. (1975) The effect of flavonoid on aerobic glycolysis and the growth of tumor cells. Cancer Res., 35, 1865-1872.
20. Verma, A., Johnsons, J. A., Gould, M. N. and Tanner, M. A. (1988) Inhibition of 7, 12-dimethylbenz(a)anthracene and N-nitrosomethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Res., 48, 5754-5758.
21. Markaverich, B. M., Roberts, R. R., Alejandro, M. A., Johnnan, G. A., Middleditch, B. S. and Clark, J. M. (1988) Bioflavonoid interaction with rat uterine type II binding sites and growth inhibition. J. Steroid Biochem., 30, 71-78.
22. Scambia, G., Ranelletti, F. O., Benedetti Panici, P., Piantelli, M., Bonanno, G , De Vincenzo, R., Ferrandina, G., Rumi, C., Larocca, L. M. and Mancuso, S. (1990) Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumors and cultured cells. Br. J. Cancer, 62, 942-946.
23. Scambia, G., Ranelletti, F. O., Benedetti Panici, P., Piantelli, M. Bonanno, G., De Vincenzo, R., Ferrandina, G., Pierelli, L., Capelli, A. and Mancuso, S (1991) Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human brest-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother. Pharmacol., 28, 255-261.
24. Ranelletti, F., Ricci, R., Larocca, L. M., Maggiano, N., Capelli, A., Scambia, G., Benedetti Panici, P., Mancuso, S. and Piantelli, M. (1992) Growth-inhibitory effect of quercetin and presence of type II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J. Cancer, 50, 486-491.
25. Scambia, G., Ranelletti, F. O., Benedetti Panici, P., Piantelli, M., Rumi, C., Battaglia, F., Larocca, L. M., Capelli, A. and Mancuso, S. (1990) Type II estrogen binding sites in a lymphoblastoid cell line and growth inhibitory effect of estrogen, antiestrogen and bioflavonoids Int. J. Cancer, 46, 1112-1116.
26. Post, J. F. M. and Varma, R. S. (1992) Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells. Cancer Lett., 67, 207-213.
27. 1 phase of the cell cycle Cancer Res., 52, 6676-6681.
28. Hoffman, R., Graham, L. and Newlands, E. S. (1989) Enhanced antiproliferative action of busulphan by quercetin on leukaemia cell line K562. Br. J. Cancer, 59, 347-348.
29. Teofili, L., Pierelli, L., Iovino, M. S , Leone, G., Scambia, G., De Vincenzo, R., Benedetti Panici, P., Menichella, G., Macri, E., Piantelli, M., Ranelletti, F. O. and Larocca, L. M. (1992) The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk. Res., 16, 497-503.
30. Larocca, L. M., Piantelli, M., Leone, G., Sica, S., Teofili, L., Benedetti Panici, P., Scambia, G., Mancuso, S., Capelli, A., Ranelletti, F. O. (1990) Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids. Brit. J. Haematol., 75, 489-495.
31. Larocca, L. M., Teofili, L., Leone, G., Sica, S., Pierelli, L., Menichella, G., Scambia, G., Benedetti Panici, P., Ricci, R., Piantelli, M. and Ranelletti, F. O. (1991) Antiproliferative activity of quercetin on normal bone marrow and leukemic progenitors. Brit. J. Haematol., 79, 562-566.
32. Larocca, L. M., Macrì, E., Ricci, R., Teofili, L., Voso, M. T., Leone, G., Scambia, G., Piantelli, M. and Ranelletti, F. O. (1992) Presence of estrogen receptor and type II estrogen binding sites in acute lymphoid and myeloid leukemic cells. Differential sensitivity of normal bone marrow and leukemic cells to quercetin inhibitory action on colony formation. In Recent advances in cellular and molecular biology (Vol. 4), edited by R. J. Wegmann and M. A. Wegmann, pp. 253-261. Leuven (Belgium): Peeters Press.
33. Larocca, L. M., Teofili, L., Sica, S., Piantelli, M., Ranelletti, F. O., Iovino, M. S. and Leone, G. (1993) Bioflavonoids: A possible tool in the therapy of acute leukemias. In Drug resistance in leukemia and lymphoma, edited by G.J.L. Kaspers, R. Pieters, P. R. Twentyman, L. M. Weisenthal and A. J. P. Veerman, pp. 271-277.
34. Larocca, L. M., Teofili, L., Sica, S., Piantelli, M., Maggiano, N., Leone, G. and Ranelletti, F. O. (1995) Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-β1 in these cells. Blood, 85, 3654-3661.
35. Ranelletti, F. O., Piantelli, M., Carbone, A., Rinelli, A., Scambia, G., Benedetti Panici, P. and Mancuso, S. (1988) Estrogen binding sites and 17 beta-hydroxysteroid dehydrogenase activity in human peripheral blood mononuclear cells. J. Clin. Endocr. Metab , 67, 888-893.
36. Clark, J. H., Hardin, J. W., Upchurch, S. and Ericksson, H. (1978) Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. J. Biol. Chem., 253, 7630-7634.
37. Ericksson, H., Upchurch, S., Hardin, J. W., Peck, E. J. Jr and Clark, J. H. (1978) Heterogeneity of estrogen receptors in the cytosol and nuclear fraction of rat uterus. Biochem. Biophvs. Res. Commun., 81, 1-7.
38. 3H)-estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Cancer Res. 44, 1575-1579.
39. 3H)-estradiol binding in rat uterine nuclei. J. Biol. Chem., 258, 663-671.
40. Markaverich, B. M., Roberts, R. R., Alejandro, M. A., Johnnan, G. A.. Middleditch, B. S. and Clark, J. M. (1988) Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J. Steroid Biochem., 30, 71-78.
41. Markaverich, B. M., Gregory, R R., Alejandro, M. A., Kittrell, F. S., Medina, D., Clark, J. M., Varma, M. and Varma, R. S. (1990) Methyl p-hydroxyphenyllactate and nuclear type II binding sites in malignant cells: metabolic fate and mammary tumor growth. Cancer Res., 50, 1470-1478
42. Piantelli, M., Rinelli, A., Macrì, E., Maggiano, N., Larocca, L. M., Scerrati, M., Roselli, R., Iacoangeli, M., Scambia, G., Capelli, A. and Ranelletti, F. O. (1993) Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer, 71, 193-198.
43. Larocca, L. M., Giustacchini, M., Maggiano, N., Ranelletti, F. O., Piantelli, M , Alcini, E. and Capelli, A. (1994) Growth-inhibitory effect of quercetin and presence of typeII estrogen binding sites in primary human transitional cell carcinoma. J. Urol., 152, 1029-1033.
44. Piantelli, M., Maggiano, N., Ricci, R., Larocca, L. M., Capelli, A., Scambia, G., Isola, G., Natali, P. G. and Ranelletti, F. O. (1995) Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J. Invest. Dermatol., 105, 248-253.
45. Ewcn, M. E., Sluss, H. K., Withohouse, L. L. and Livingston, D. N. (1993) TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell, 74, 1009-1020.
46. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
47. INK4B is a potential effector of TFG-β1-induced cell cycle arrest. Nature, 371, 257-261.
48. Elia, G. and Santoro, M. G. (1994) Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells. Biochem. J., 300, 201-209.
49. Wei, Y. Q., Zhao, X., Kariya, Y., Fukata, H., Teshigawara, K. and Uchida, A. (1994) Induction of apoptosis by quercetin: involvment of heat shock protein Cancer Res., 54, 4952-4957.
50. + chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-, TNF, and quercetin; its application to autologous bone marrow transplantation for CML. Exp. Hematol., 23, 442-452.
51. Gugler, R., Lschik, M. and Dengler, M. J. (1975) Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol., 9, 229-235.